Inactive Instrument

News Mylan Inc Nasdaq

Equities

US6285301072

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Jul. 03	Viatris Divests Over-the-Counter Business to Cooper Consumer Health	MT
Jul. 03	Cooper Consumer Health SAS completed the acquisition of Substantially All of the Over-the-Counter Business of Viatris Inc..	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Calliditas Therapeutics AB - Launch of Phase 3 clinical trial with Nefecon in Japan	Jul. 05	AQ
Launch of Phase 3 clinical trial with Nefecon in Japan	Jul. 04	AQ
Viatris Divests Over-the-Counter Business to Cooper Consumer Health	Jul. 03	MT
Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture	Jul. 03	PR
Cooper Consumer Health SAS completed the acquisition of Substantially All of the Over-the-Counter Business of Viatris Inc..	Jul. 02	CI
Viatris : Mylan No Longer Subject of Antitrust Investigation by Justice Dept	Jul. 02	DJ
Viatris Says US Department of Justice's Antitrust Division No Longer Considers Mylan Subject of Investigation	Jul. 02	MT
US DOJ drops Viatris unit Mylan from industry-wide antitrust probe	Jul. 02	RE
US DOJ informs Viatris' Mylan is no longer part of antitrust investigation	Jul. 02	RE
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation	Jul. 02	PR
European Commission Conditionally Approves Cooper-Viatris Deal	Jun. 27	MT
Viatris : Statement Regarding European Commission’s Approval for Proposed Divestiture of its Over the Counter Business to Cooper Consumer Health	Jun. 26	PU
Viatris Named to TIME's World's Most Sustainable Companies 2024 List	Jun. 25	PR
Transcript : Viatris Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 09:20 AM	Jun. 11
Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024	Jun. 07	PR
Transcript : Viatris Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 08:00 AM	Jun. 06
Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference	Jun. 04	PR
Viatris : Statement on the Close of the Active Pharmaceutical Ingredients Business Divestiture	Jun. 03	PU
Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors	Jun. 03	PR
Viatris Inc. Appoints Rogerio Vivaldi Coelho to Board of Directors	Jun. 03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Mylan Inc Nasdaq

Equities

US6285301072

Summary

Filters